Безопасен ли palmitoyl tripeptide-56 при беременности?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR reproductive safety flags were identified for palmitoyl tripeptide-56. No peer‑reviewed reports of developmental/reproductive toxicity were found in the literature. Topical peptides of this class are large molecules with low systemic absorption, but palmitoylation increases lipophilicity so low but measurable dermal uptake is plausible (hence e=1). Sources: ECHA Annex VI (no harmonised classification), CIR (no safety concern noted for cosmetic peptides generally), PubMed (no reproductive/toxicity studies found).
Pregnancy-safe products containing palmitoyl tripeptide-56
Related ingredients
Frequently asked questions
- Безопасен ли palmitoyl tripeptide-56 при беременности?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR reproductive safety flags were identified for palmitoyl tripeptide-56. No peer‑reviewed reports of developmental/reproductive toxicity were found in the literature. Topical peptides of this class are large molecules with low systemic absorption, but palmitoylation increases lipophilicity so low but measurable dermal uptake is plausible (hence e=1). Sources: ECHA Annex VI (no harmonised classification), CIR (no safety concern noted for cosmetic peptides generally), PubMed (no reproductive/toxicity studies found).
- Безопасен ли palmitoyl tripeptide-56 при грудном вскармливании?
- No evidence of reproductive or lactation-specific toxicity; no mechanistic data indicating transfer into breastmilk. Given low expected systemic exposure after topical use, systemic levels are likely minimal but not zero, so exposure is low/measurable. Sources: PubMed (no relevant studies), ECHA (no harmonised classification), PubChem/CosIng (ingredient identity/uses).
- Безопасен ли palmitoyl tripeptide-56 для кожи малыша?
- No infant‑specific toxicity or developmental effects reported. Per guidance, infant skin has higher per‑kg exposure and a less mature barrier; for an ingredient with low but measurable adult absorption (e=1), increase exposure score by +1 for babies (e=2). No data support increased hazard or specific mechanisms in infants. Sources: PubMed (no infant toxicity data), CosIng/PubChem (ingredient info).
- Как VeriMom оценивает palmitoyl tripeptide-56?
- VeriMom оценивает palmitoyl tripeptide-56 в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы palmitoyl tripeptide-56 при беременности?
- См. наш список безопасных альтернатив palmitoyl tripeptide-56 с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.
